ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

BMRA Biomerica Inc

0.586
0.0054 (0.93%)
Jun 03 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 14,984
Bid Price 0.5603
Ask Price 0.5854
News -
Day High 0.618

Low
0.50

52 Week Range

High
2.13

Day Low 0.5555
Company Name Stock Ticker Symbol Market Type
Biomerica Inc BMRA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0054 0.93% 0.586 18:59:01
Open Price Low Price High Price Close Price Prev Close
0.581 0.5555 0.618 0.586 0.5806
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
172 14,984 $ 0.5835576 $ 8,744 - 0.50 - 2.13
Last Trade Time Type Quantity Stock Price Currency
16:00:00 512 $ 0.586 USD

Biomerica Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
9.92M 16.82M - 5.34M -7.14M -0.42 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Biomerica News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No BMRA Message Board. Create One! See More Posts on BMRA Message Board See More Message Board Posts

Historical BMRA Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.6260.660.55550.605683554,644-0.04-6.39%
1 Month0.55560.6870.5110.6048139146,0440.03045.47%
3 Months1.091.190.500.6072954248,101-0.504-46.24%
6 Months0.9252.130.501.43735,201-0.339-36.65%
1 Year1.242.130.501.44437,532-0.654-52.74%
3 Years3.56697.380.503.90389,858-2.98-83.57%
5 Years2.2523.390.505.82412,024-1.66-73.96%

Biomerica Description

Biomerica Inc is engaged in the development, manufacturing, and marketing medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. Majority of the company's revenue is earned from the Europe market.